RESULTS
Figures 1 and 2 describe the production of conjugated dienes when the water-soluble antioxidants, vitamin C and uric acid, were added to LDL, re spectively.
Vitamin C prolonged the lag time ( Fig. 1 ) in a dose-dependent manner. Compared with the control, the lag time was prolonged 1.3 times in the presence of 0.07mg/dL vitamin C, 1.7 times at 0.14mg/dL, 3.4 times at 0.35mg/dL and 4.1 times at 0.7mg/dL.
Similar results were observed with uric acid. Figure 2 shows that the lag time individual subjects and the conditions of the experiments also differed. When vitamin E and uric acid were added together, the lag time was 262.4min (1.5mg/dL vitamin E and 0.2mg/dL uric acid) or 277.1min (3mg/dL vitamin E and 0.2mg/dL uric acid). Further, when the uric acid dose was increased to 0.4mg/dL, lag times were extended longer. of the oxidation lag time in LDL. When vitamin C is added to the aqueous phase, the rate of vitamin E consumption is reduced markedly; presumably vitamin C is an effective regenerator of vitamin E from vitamin E radical (17) . Our results in the interaction between vitamin E and vitamin C are supported by previous studies.
DISCUSSION
On the other hand, the lag time which was shortened by the addition of 3mg/dL of vitamin E also recovered in the presence of uric acid in the same way as that of vitamin C. However, it has been reported elsewhere that unlike vitamin C, uric acid does not reduce vitamin E radicals in lipid dispersion (18, 19) . Further studies are needed to classify this difference.
The above results suggest that in vitro water-soluble antioxidants provide complementary actions to the antioxidant activity of vitamin E directly or indirectly.
It has been reported that probucol inhibits the oxidation of LDL as efficiently as vitamin E, and both are consumed independently during LDL oxidation (20) ; that is, without sparing vitamin E. Probucol, a combination of two butylated hydroxytoluene (BHT) molecules coupled by an "-S-C-S-" group, is a lipophilic antioxidant and previously used as a lipid lowering drug. It is carried within LDL particles in plasma and effectively suppresses the oxidative modification of LDL in a dose-dependent manner (20) (21) (22) (23) (24) . The lag time, which was extended dose dependently up to 1mg/dL of probucol, was shortened at higher doses of 2mg/dL (Table 2) for reasons which remain unclear. Probucol may act similarly in properties to vitamin E as a prooxidant, but this action has never been reported. More research is needed to clarify the mechanisms of action of probucol at higher concentrations, including identification of the probucol degradation products.
In conclusion, our study provides evidence that LDL-oxidative resistance is enhanced by the interaction of combined lipid and water-soluble antioxidants existing within the lipid and aqueous phases, respectively. These results were obtained using a new assay method that utilizes an azo-radical initiator. Thus, the total radical trapping capacity of antioxidants is an important determinant of LDL oxidation in human plasma, an aerobic organism.
